Tempus soars 15% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI

TechCrunch

Tempus, a genomic testing and data analysis company started by Eric Lefkosky, who previously founded Groupon, debuted on Nasdaq on Friday, rose about 15% on the opening. The company priced its IPO on Thursday at $37 apiece, at the top of its $35 to $3…